Yan-ming Deng

发表

Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors

L. Shen, Jian Li, S. Qin, 2021, Journal of Hematology & Oncology.

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer

R. Salem, J. Lacy, B. Chang, 2016, British Journal of Cancer.

Anlotinib monotherapy for refractory metastatic colorectal cancer: A double-blinded, placebo controlled, randomized Phase III trial (ALTER0703).

Ying Cheng, Y. Ba, Jianming Xu, 2021, The oncologist.

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

H. Xiang, Xianghui Qi, Jing-wen Ai, 2022, Hepatology International.

[Association of RAS mutations in circulating cell-free DNA in the plasma with clinicopathological features of colorectal cancer].

Wei Wang, Lirong Zhao, Xiuli Lin, 2017, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma

Fenghua Wang, Wen-Qi Jiang, Yu-hong Li, 2008, Cancer Chemotherapy and Pharmacology.

Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, observational, non-interventional phase IV trial

W. Wang, Fenghua Wang, Su-zhan Zhang, 2021, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study

K. Tao, Jun Zhang, Jian Li, 2022, The oncologist.

Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma

J. Lacy, J. Kortmansky, H. Hochster, 2017, American journal of clinical oncology.

Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China.

X. An, Fenghua Wang, Yu-hong Li, 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

EGFR Fluorescence In situ Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients

X. An, Fenghua Wang, J. Shao, 2011, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine EGFR Fluorescence In situ Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients

X. An, Fenghua Wang, J. Shao, 2011 .